Searcharxiv⌕ Search

arXiv subjects

Parag J. Parikh

Publications and source records attributed to Parag J. Parikh.

2 recordsLinked to original sources

Prior-Guided Physics-Informed Deep Learning for Fast 4D MRI Reconstruction

Background and purpose: We propose PGPI4MR (prior-guided, physics-informed 4D MRI reconstruction), a deep learning method that leverages information from other respiratory phases or a setup scan, the first 30 s of the same scan, to improve 4D MRI reconstruction without extra scan time. Materials and methods: PGPI4MR is an unrolled network that reconstructs 16 respiratory phases from 60, 30, or 15 s of data, and single 3D volumes, each from 0.29-0.49 s of data, using a setup-scan image. The networks were trained once, on other volunteers, and were not retrained for new volunteers. We evaluated PGPI4MR on measured k-space from three datasets: free-breathing MR-linac (1.5T) and abdominal (3T) scans, and thigh scans with cuff compression (1.5T). All methods, including comparative models, received identical samples and were scored similarly. Results: In vivo, PGPI4MR had the lowest held-out error for 4D MRI at every scan time, and its 16 phases were ready a median of 7.5-13 s after the scan on the 2 GPUs tested. Coupling the 16 respiratory phases reduced the error at 60 s by 9.1% compared with reconstructing each phase alone. For sub-second MRI, the error at 0.49 s was 15.5% lower than that of the best comparison method, classical reconstruction toward the same prior, and on the faster GPU, every 0.29 s window was acquired and reconstructed within 0.5 s. Without retraining, PGPI4MR matched the best methods on the 3T abdominal scans but not on the thigh scans; after retraining on thigh data, it reduced the held-out error by 6.6% relative to the best comparison method. Conclusion: Prior information allowed PGPI4MR to reconstruct 4D and sub-second MRI more accurately than compressed sensing and a published 4D network, within seconds and without extra scan time. This could support 4D MRI for treatment planning and 3D motion monitoring during MR-guided radiotherapy.

cs.CV↗

Segment Anything Pancreas: A Unified MRI Segmentation Model for Pancreatic Cancer Radiotherapy

Background: Limited tumor annotations and incomplete labels across MRI datasets hinder unified segmentation of pancreatic tumors and organs at risk (OARs) for MRI-guided radiotherapy. Purpose: We propose Pancreas-MedNeXt, a unified model that segments the whole pancreas, its subregions, tumors, and surrounding OARs from one MRI volume. Methods: The model uses a shared MedNeXt encoder-decoder with supervised whole-pancreas and subregion pretraining, followed by multitask fine-tuning. Three output heads predict the pancreatic subregions, tumor, and OARs (stomach, duodenum, kidneys). An annotation-aware loss allows training on partially labeled data without treating unannotated structures as background. Pancreas and tumor were evaluated by three-fold cross-validation on 142 PANTHER patients (92 diagnostic, 50 MR-Linac), subregions and OARs on Cyst-X and AMOS test sets, and pancreas and OARs on 33 external T1-weighted TotalSegmentator scans. Comparisons with nnU-Net, MedNeXt, VISTA3D, and Swin UNETR used the Dice similarity coefficient (DSC) with paired bootstrap 95% CIs. Results: Pancreas-MedNeXt achieved the highest mean pancreas and tumor DSC on diagnostic and MR-Linac MRI. Tumor DSC was 58.41% and 42.55%, exceeding task-specific MedNeXt by 4.94 (95% CI: 0.28-9.45) and 5.89 (95% CI: 2.37-9.72) percentage points, respectively. Whole-pancreas DSC was 85.73% and 70.66%. Pretraining improved head, body, and tail DSC by 2.01, 3.00, and 3.78 percentage points over training from scratch. It also achieved the highest DSC for the pancreas, duodenum, and right kidney on AMOS, and for all five organs on external MRI, exceeding the next-best method by 4.92-8.85 percentage points.Conclusion: A single Pancreas-MedNeXt model segments tumors, pancreatic subregions, and OARs on diagnostic and MR-Linac MRI, which could streamline contouring for pancreatic cancer radiotherapy.

cs.CV↗